New Pharmacogenomics Research Network: An Open Community Catalyzing Research and Translation in Precision Medicine

M. V. Relling, R. M. Krauss, D. M. Roden, T. E. Klein, D. M. Fowler, N. Terada, L. Lin, M. Riel-Mehan, T. P. Do, M. Kubo, S. W. Yee, G. T. Johnson, K. M. Giacomini

研究成果: Comment/debate査読

17 被引用数 (Scopus)

抄録

The goal of pharmacogenomics research is to discover genetic polymorphisms that underlie variation in drug response. Increasingly, pharmacogenomics research involves large numbers of patients and the application of new technologies and methodologies to enable discovery. The Pharmacogenomics Research Network (PGRN) has become a community-driven network of investigators spanning scientific and clinical disciplines. Here, we highlight the activities and types of resources that enable PGRN members to enhance and drive basic and translational research in pharmacogenomics.

本文言語English
ページ(範囲)897-902
ページ数6
ジャーナルClinical Pharmacology and Therapeutics
102
6
DOI
出版ステータスPublished - 12-2017

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmacology (medical)

フィンガープリント 「New Pharmacogenomics Research Network: An Open Community Catalyzing Research and Translation in Precision Medicine」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル